seekingalpha.com / .seekingalpha-com

CURE ETF slid in early 2026 as investors take profits.

Globant S.A. stock has plunged 73% as growth stalls, but now trades at a single-digit P/E. Click for this GLOB update and see why I am bullish now.

Sysco (SYY) buy? Explore the $29B Jetro deal, 20% revenue upside, $250M synergies, 3% Dividend King yield, and sub-16x value--click to read now.

Historically high buying in 2X/3X ProShares short vs. long funds often signals market bottoms and rallies. Read more macro analysis here.

Eli Lilly (LLY) stays a Buy after a 12% dip: Zepbound cuts and slower growth weigh now, but orforglipron FDA nod and CNTA deal fuel upside. Read the latest analysis on the stock here.

Apple Inc. stock slid on foldable iPhone delay reports. Get analysis on Apple's pricing edge amid a memory crisis, ASP upside, and more. Click for this AAPL update.

Initiate a Buy on iShares Core Dividend Growth ETF (DGRO): quality dividend growth, overweight financials, defensiveness, and long-term upside.

ASML Holding (ASML) stock review: Discover why ASML has an A+ Profitability grade and $14B in cash from operations despite its Quant Hold rating in this 2-Minute Analysis.

Mesoblast Limited is upgraded to Buy as Ryoncil outperforms in pediatric SR-aGVHD and advances rapidly into DMD trial. Read more on MESO stock here.

Repligen stock returns to double-digit growth but remains a "Hold." Here's what investors need to know.